Canada's Biotech Reboot and Life Sciences Sector Challenges

This report examines the current state of Canada's life sciences sector, highlighting its historical strengths and emerging challenges. The life sciences sector has been pivotal in establishing Canada as a leader in drug discovery and healthcare innovation, contributing significantly to economic growth and employment. However, recent trends indicate a decline in the sector's ability to translate research into commercial success, leading to a shift from being a net exporter to a net importer of pharmaceuticals. The report emphasizes the need for increased investment and better coordination of resources to enhance productivity and innovation. It also discusses the implications of the COVID-19 pandemic on domestic production capacity and the growing demand for health-related products due to an aging population. The report calls for strategic changes in funding and support mechanisms to ensure the sector remains a foundational pillar of economic resilience and is better prepared for future public health challenges.